{"id":35031,"date":"2022-11-15T11:46:24","date_gmt":"2022-11-15T10:46:24","guid":{"rendered":"https:\/\/semmelweis.hu\/english\/?p=35031"},"modified":"2022-12-01T08:31:31","modified_gmt":"2022-12-01T07:31:31","slug":"closer-relationship-semmelweis-karolinska-pathology-symposium","status":"publish","type":"post","link":"https:\/\/semmelweis.hu\/english\/2022\/11\/closer-relationship-semmelweis-karolinska-pathology-symposium\/","title":{"rendered":"Strengthened relationship \u2013 Semmelweis-Karolinska Pathology Symposium"},"content":{"rendered":"
The second Bilateral Pathology Symposium of Semmelweis University and Karolinska University was held in Budapest, at the Department of Pathology and Experimental Cancer Research of the university, on 11-12 November, in the framework of the Dies Academicus ceremony. Leading representatives from the fields of radiology, laboratory medicine and pathology met to share their knowledge and inform colleagues about the latest scientific discoveries.<\/div>\n

\u201eIf everyone moves forward together, success takes care of itself\u201d. Dr. B\u00e9la Merkely, Rector of Semmelweis University opened the Bilateral Pathology Symposium with the words of Henry Ford. He recalled that the connection between Karolinska Univerity and Semmelweis University began 12 years ago.<\/p>\n

\"\"<\/a><\/p>\n

\u201cSince then, we have proven that we can indeed achieve a lot together \u2013 we have worked very hard to achieve success. We have developed a very close professional relationship between our institutions, with many of our staff members visiting Sweden for longer or shorter periods of time, and we have also had the opportunity to host several specialists from our partners in Budapest. In 2019, we signed a bilateral agreement on science, education and diagnostic care, and our first bilateral congress took place in the same year,\u201d the rector explained.<\/p>\n

He pointed out that the relationship between the two institutions has already been fruitful, with numerous scientific collaborations, joint publications and working groups. \u201cAfter this second symposium, the number is expected to grow: this year, leading representatives from radiology, laboratory medicine and pathology came together to share their knowledge, inform colleagues about the latest scientific discoveries and, build relationships,\u201d Dr. B\u00e9la Merkely said.<\/p>\n

He emphasized that both Semmelweis and Karolinska strive for excellence, and are committed to treating patients and educating students to the highest standards. In the field of medicine and health sciences, both universities are considered to be the region’s inescapable knowledge centers. Karolinska is ranked 49th in the latest Times Higher Education world rankings, while Semmelweis is the first university in Central and Eastern Europe to be included in the top 250.<\/p>\n

\"\"<\/a><\/p>\n

Dr. Mathias Axelsson, head of Medical Diagnostics Karolinska, Karolinska University stressed that the future of healthcare requires cutting edge technology, advanced specialization and collaboration. He presented that their institution \u2013 including Imaging and Physiological Medicine, Clinical Laboratory Medicine, and Biobank and Study Center \u2013 is a competence and technical leading center in diagnostics, intervention and treatment, according to the patients need today and in the future.<\/p>\n

Dr. Axelsson presented the unique collaboration at Precision Medicine Center Karolinska with the following main characteristics:<\/p>\n

– new seamless organization, heads of the Karolinska Univerity Hospital and Institute deeply engaged<\/p>\n

– cross collaboration between disciplines, academy and health care<\/p>\n

– sharing knowledge and infrastructure<\/p>\n

– geographic proximity<\/p>\n

– testbeds for industrial collaboration<\/p>\n

Dr. Joakim Dillner, Head of Unit of the Center for Cervical Cancer Prevention at the Karolinska University Hospital, made a keynote speech entitled “Elimination of cervical cancer and the role of Human Papillomavirus genotyping”.<\/p>\n

\"\"<\/a><\/p>\n

He outlined the major strategies for cervical cancer elimination: HPV vaccination to stop the circulation of HPV, as soon as possible and to offer HPV screening to those who may have been infected and developed a cancer precursor before HPV circulation was stopped.<\/p>\n

Dr. Dillner stressed the importance of a maximally effective and convenient screening program.\u00a0\u201cYesterday it was ‘one size fits all’ with appointments, the entire population was summoned to screening at regular intervals. Today there is self-sampling at home, offered for the entire population, and tomorrow will be self-sampling \u2013 by the women who actually need screening,\u201d he pointed out.<\/p>\n

Mentioning the challenges, Dr. Dillner emphasized the following:<\/p>\n

– Several million women who do not need screening are screened.<\/p>\n

– No particular priority is given to the small number of women who have high cervical cancer risk.<\/p>\n

– With the introduction of HPV genotyping in the screening program risk differences (on file in lab databases) are several thousand fold.<\/span>\u00a0<\/span><\/p>\n

– Results on risks are not clearly conveyed to women.\u00a0<\/span><\/p>\n

The Karolinska professor recalled that the World Health Organization (WHO) declared the global elimination of cervical cancer as a prioritized aim in 2016, and that this was adopted by the World Medical Assembly in 2020.<\/p>\n

\n

The following lectures were made at the bilateral symposium:<\/strong><\/p>\n

    \n
  • Nanobiophisics of the coronavirus \u2013 Mikl\u00f3s Kellermayer, Department of Biophysics and Radiation Biology, Semmelweis University<\/li>\n
  • Covid-19 and post-COVID associated pathologies \u2013 L\u00e1szl\u00f3 Sz\u00e9kely, Clinical Pathology and Cancerdiagnostics, Medical Diagnostics Karolinska, Karolinska University Hospital<\/li>\n
  • COVID-19 associated cause of death and liver pathology in autopsy cases \u2013 Andr\u00e1s Kiss, Department of Pathology, Forensic and Insurance Medicine, Semmelweis University<\/li>\n
  • Detection of SARRS-COV2 and covid associated pathology in autopsy cases \u2013 Tibor V\u00e1rkonyi, Department of Pathology, Forensic and Insurance Medicine, Semmelweis University<\/li>\n
  • Placental pathology in maternal SARS-COV2 infection \u2013 Nikos Papadogiannakis, Clinical Pathology and Cancerdiagnostcs, Medical Diagnostics Karolinska, Karolinska University Hospital<\/li>\n
  • Cell Plasticity as a diagnostic tool and therapeutic target in cancer \u2013 Jonas Fuxe, Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet<\/li>\n
  • Modelling metabolic heterogeneity in cancer \u2013 Anna Sebesty\u00e9n, Department of Pathology and Experimental Cancer Research, Semmelweis University<\/li>\n
  • Cancer proteogenomics for precision medicine diagnostics \u2013 Janne Lehti\u00f6, Clinical Pathology and Cancerdiagnostcs, Medical Diagnostics Karolinska, Karolinska University Hospital<\/li>\n
  • The role of extracellular matrix in cancer progression \u2013 Korn\u00e9lia Baghy, Department of Pathology
    \nand Experimental Cancer Research, Semmelweis University<\/li>\n
  • Sex dimorphism in the immune tumor microenvironment \u2013 Toward \u201cGenderized immunotherapy\u201d \u2013 Dhifaf Sarhan, Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet<\/li>\n
  • Phenotypic drug screening to target invasive cancer \u2013 Lars Holmgren, Department of OncologPathology, Karolinska Institutet<\/li>\n
  • Tumor specific enzyme assisted chemotherapy \u2013 a novel approach to treat liver cancer \u2013 Arun
    \nSelvam, Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet<\/li>\n
  • Cellular Energetics in liver regeneration \u2013 Andr\u00e1s Budai, Department of Pathology, Forensic and
    \nInsurance Medicine, Semmelweis University<\/li>\n
  • 30 years of clinical liver cell treatments: from hepatocyte transplantation to new perinatal stem cell \u2013 Roberto Gramignoli, Clinical Pathology and Cancerdiagnostics, Medical Diagnostics Karolinska, Karolinska University Hospital<\/li>\n
  • Tumor spread and \u201ccross-talk\u201d in the liver \u2013 B\u00e9la Boz\u00f3ky, Clinical Pathology and Cancerdiagnostics, Medical Diagnostics Karolinska, Karolinska University Hospital<\/li>\n
  • Human papillomavirus (HPV) in oropharyngeal cancer \u2013 approaching individualized treatment \u2013 Anders N\u00e4sman, Clinical Pathology and Cancerdiagnostics, Medical Diagnostics Karolinska, Karolinska University Hospital<\/li>\n
  • Digital image analysis in colorectal cancer \u2013 Anna Jakab, Department of Pathology and Experimental Cancer Research, Semmelweis University<\/li>\n
  • Detection of H. Pylori and its chlaritromycin resistance in routine pathological diagnostics \u2013 G\u00e1bor Lotz, Department of Pathology, Forensic and Insurance Medicine, Semmelweis University<\/li>\n
  • AI based colorectal cancer screening decision support. Endre Kontsek, Department of Pathology, Forensic and Insurance Medicine, Semmelweis University<\/li>\n
  • Sodium selenite-induced tumor-specific cytotoxicity in a tissue slice model of human pancreatic ductal adenocarcinoma \u2013 Carlos Fernandez Moro, Clinical Pathology and Cancerdiagnostics, Medical Diagnostics Karolinska, Karolinska University Hospital<\/li>\n
  • Analysis of pancreatic cancer at the molecular level for developing selenium-based therapy \u2013 T\u00edmea Szekercz\u00e9s, Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet<\/li>\n
  • Molecular Diagnosis of Malignant Mesothelioma \u2013 Katalin Dobra, Clinical Pathology and Cancerdiagnostics, Medical Diagnostics Karolinska, Karolinska University Hospital<\/li>\n
  • Validation of multiple IHC based digital pathodiagnostics method in renal biopsy samples \u2013 Dej\u00e1n
    \nDobi Department of Pathology, Forensic and Insurance Medicine, Semmelweis University<\/li>\n
  • Klotho in kidney disease and aging \u2013 Hannes Olauson, Clinical Pathology and Cancerdiagnostics,
    \nMedical Diagnostics Karolinska, Karolinska University Hospital<\/li>\n
  • Molecular monitoring of the transplanted kidney and heart \u2013 Attila Fintha, Department of
    \nPathology and Experimental Cancer Research, Semmelweis University<\/li>\n
  • High throughput RNA profiling of renal glomerular tissue in health and disease \u2013 Jaakko Patrakka, Clinical Pathology and Cancerdiagnostics, Medical Diagnostics Karolinska, Karolinska University Hospital<\/li>\n
  • Multiplexed mapping of the immune cell landscape in advanced bladder cancer \u2013 David Krantz, Clinical Pathology and Cancerdiagnostcs, Medical Diagnostics Karolinska, Karolinska University Hospital<\/li>\n
  • AI-based precision diagnostics in breast pathology \u2013 Johan Hartman, Clinical Pathology and Cancerdiagnostics, Medical Diagnostics Karolinska, Karolinska University Hospital<\/li>\n
  • HPV status and prognosis in invasive cervical cancer \u2013 prospects for improved prediction? \u2013 Karin Sundstr\u00f6m, Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet<\/li>\n
  • Immunogenic mimicry of melanoma and other cancers \u2013 J\u00f3zsef T\u00edm\u00e1r, Department of Pathology, Forensic and Insurance Medicine, Semmelweis University<\/li>\n
  • Cutting \u2013 edge precisionmedicine in public health care at Karolinska University Hospital \u2013 Maria Johansson Soller, Clinical Pathology and Cancerdiagnostics, Medical Diagnostics Karolinska, Karolinska University Hospital<\/li>\n
  • Molecular oncogenomic facilities at Semmelweis University \u2013 Csaba B\u00f6d\u00f6r, Department of
    \nPathology and Experimental Cancer Research, Semmelweis University<\/li>\n
  • Comprehensive oncogenomic profiling in pediatric malignancies \u2013 G\u00e1bor Bedics, Department of
    \nPathology and Experimental Cancer Research, Semmelweis University<\/li>\n
  • Precision medicine in cancer \u2013 the role of our microbiome \u2013 Lars Engstrand, Clinical Pathology and
    \nCancerdiagnostics, Medical Diagnostics Karolinska, Karolinska University Hospital<\/li>\n
  • Comprehensive genomic profiling of adult-type diffuse high-grade gliomas \u2013 B\u00e1lint Scheich,
    \nDepartment of Pathology and Experimental Cancer Research, Semmelweis University<\/li>\n
  • Next-generation sequencing in inherited cardiovascular diseases \u2013 Be\u00e1ta Nagy, Katalin Csonka, Department of Pathology and Experimental Cancer Research, Semmelweis University<\/li>\n
  • The Hungarian Pediatric Leukemia Genomic Program \u2013 Borb\u00e1la P\u00e9terffy, Department of Pathology
    \nand Experimental Cancer Research, Semmelweis University<\/li>\n
  • Human myeloid cells in tissue: from inflammation to cance \u2013 Egle Kvedaraite, Clinical Pathology
    \nand Cancerdiagnostics, Medical Diagnostics Karolinska, Karolinska University Hospital<\/li>\n
  • Germline GATA2 mutations in familial MDS\/AML: a manually curated online registry from the ERAPERMED GATA2-HuMo international consortium \u2013 Lili Kotmayer, Department of Pathology and Experimental Cancer Research, Semmelweis University<\/li>\n
  • Activation of telomerase in aggressive thyroid tumors \u2013 Catharina Larsson, Department of Oncology-Pathology, Karolinska Institutet<\/li>\n
  • Spatial and temporal profiling in B-cell lymphomas using integrative tissue- and liquid biopsies \u2013 Bence B\u00e1tai, Department of Pathology and Experimental Cancer Research, Semmelweis University<\/li>\n
  • Chalenges of medical training in the 21th century \u2013 Mikl\u00f3s Kellermayer, Dean of Faculty of Medicine, Semmelweis University<\/li>\n
  • Undergraduate training in pathology at Karolinska Institute \u2013 Monika Klimkowska\/ Katalin Dobra, Clinical Pathology and Cancerdiagnostics, Medical Diagnostics Karolinska, Karolinska University Hospital<\/li>\n
  • Pathology Core Facility Karolinska. Meriana Findakly, Clinical Pathology and Cancerdiagnostics, Medical Diagnostics Karolinska, Karolinska University Hospital<\/li>\n
  • Digital pathology: a tool of integration \u2013 Attila Szakos, Clinical Pathology and Cancerdiagnostics, Medical Diagnostics Karolinska, Karolinska University Hospital<\/li>\n
  • Specialist training at Karolinska \u2013 Sulaf Abd Own, Clinical Pathology and Cancerdiagnostics, Medical Diagnostics Karolinska, Karolinska University Hospital<\/li>\n
  • Residence training of pathology in Semmelweis University \u2013 Zolt\u00e1n S\u00e1pi, Program director of the residence training, Department of Pathology and Experimental Cancer Research, Semmelweis University<\/li>\n
  • Doctoral School of pathological sciences in Semmelweis University \u2013 Andr\u00e1s Matolcsy, Doctoral School of Pathology Science, Semmelweis University<\/li>\n<\/ul>\n<\/div>\n

     <\/p>\n

    \n

    G\u00e1bor Kiss<\/p>\n

    Photo: B\u00e1lint Barta \u2013 Semmelweis University<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

    Representatives of the two universities from the fields of radiology, laboratory medicine and pathology shared their knowledge.<\/p>\n","protected":false},"author":102061,"featured_media":35096,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[13,17,286],"tags":[121,202],"class_list":["post-35031","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-science","category-semmelweis-world","category-x-nyitolap","tag-science","tag-scientific-events"],"acf":[],"_links":{"self":[{"href":"https:\/\/semmelweis.hu\/english\/wp-json\/wp\/v2\/posts\/35031","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/semmelweis.hu\/english\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/semmelweis.hu\/english\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/english\/wp-json\/wp\/v2\/users\/102061"}],"replies":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/english\/wp-json\/wp\/v2\/comments?post=35031"}],"version-history":[{"count":10,"href":"https:\/\/semmelweis.hu\/english\/wp-json\/wp\/v2\/posts\/35031\/revisions"}],"predecessor-version":[{"id":35267,"href":"https:\/\/semmelweis.hu\/english\/wp-json\/wp\/v2\/posts\/35031\/revisions\/35267"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/english\/wp-json\/wp\/v2\/media\/35096"}],"wp:attachment":[{"href":"https:\/\/semmelweis.hu\/english\/wp-json\/wp\/v2\/media?parent=35031"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/semmelweis.hu\/english\/wp-json\/wp\/v2\/categories?post=35031"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/semmelweis.hu\/english\/wp-json\/wp\/v2\/tags?post=35031"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}